Literature DB >> 26338914

Gray Matter Volume Reduction Is Associated with Cognitive Impairment in Neuromyelitis Optica.

Q Wang1, N Zhang1, W Qin1, Y Li2, Y Fu2, T Li2, J Shao2, L Yang2, F-D Shi3, C Yu4.   

Abstract

BACKGROUND AND
PURPOSE: Whether gray matter impairment occurs in neuromyelitis optica is a matter of ongoing debate, and the association of gray matter impairment with cognitive deficits remains largely unknown. The purpose of this study was to investigate gray matter volume reductions and their association with cognitive decline in patients with neuromyelitis optica.
MATERIALS AND METHODS: This study included 50 patients with neuromyelitis optica and 50 sex-, age-, handedness-, and education-matched healthy subjects who underwent high-resolution structural MR imaging examinations and a battery of cognitive assessments. Gray matter volume and cognitive differences were compared between the 2 groups. The correlations of the regional gray matter volume with cognitive scores and clinical variables were explored in the patients with neuromyelitis optica.
RESULTS: Compared with healthy controls (635.9 ± 51.18 mL), patients with neuromyelitis optica (602.8 ± 51.03 mL) had a 5.21% decrease in the mean gray matter volume of the whole brain (P < .001). The significant gray matter volume reduction in neuromyelitis optica affected the frontal and temporal cortices and the right thalamus (false discovery rate correction, P < .05). The regional gray matter volumes in the frontal and temporal cortices were negatively correlated with disease severity in patients with neuromyelitis optica (Alphasim correction, P < .05). Patients with neuromyelitis optica had impairments in memory, information processing speed, and verbal fluency (P < .05), which were correlated with gray matter volume reductions in the medial prefrontal cortex and thalamus (Alphasim correction, P < .05).
CONCLUSIONS: Gray matter volume reduction is present in patients with neuromyelitis optica and is associated with cognitive impairment and disease severity in this group.
© 2015 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2015        PMID: 26338914      PMCID: PMC7965033          DOI: 10.3174/ajnr.A4403

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  39 in total

1.  Cortical thinning correlates with cognitive change in multiple sclerosis but not in neuromyelitis optica.

Authors:  Yaou Liu; Teng Xie; Yong He; Yunyun Duan; Jing Huang; Zhuoqiong Ren; Gaolang Gong; Jun Wang; Jing Ye; Huiqing Dong; Helmut Butzkueven; Fu-Dong Shi; Ni Shu; Kuncheng Li
Journal:  Eur Radiol       Date:  2014-06-07       Impact factor: 5.315

2.  No MRI evidence of cortical lesions in neuromyelitis optica.

Authors:  Massimiliano Calabrese; Mi Sun Oh; Alice Favaretto; Francesca Rinaldi; Valentina Poretto; Sara Alessio; Byung-Chul Lee; Kyung-Ho Yu; Hyeo-Il Ma; Paola Perini; Paolo Gallo
Journal:  Neurology       Date:  2012-09-19       Impact factor: 9.910

3.  Cognitive performance of neuromyelitis optica patients: comparison with multiple sclerosis.

Authors:  Sandra Vanotti; Evangelina Valeria Cores; Barbara Eizaguirre; Luciana Melamud; Raúl Rey; Andrés Villa
Journal:  Arq Neuropsiquiatr       Date:  2013-06       Impact factor: 1.420

4.  Revised diagnostic criteria for neuromyelitis optica.

Authors:  D M Wingerchuk; V A Lennon; S J Pittock; C F Lucchinetti; B G Weinshenker
Journal:  Neurology       Date:  2006-05-23       Impact factor: 9.910

5.  Brain abnormalities in neuromyelitis optica.

Authors:  Sean J Pittock; Vanda A Lennon; Karl Krecke; Dean M Wingerchuk; Claudia F Lucchinetti; Brian G Weinshenker
Journal:  Arch Neurol       Date:  2006-03

Review 6.  The spectrum of neuromyelitis optica.

Authors:  Dean M Wingerchuk; Vanda A Lennon; Claudia F Lucchinetti; Sean J Pittock; Brian G Weinshenker
Journal:  Lancet Neurol       Date:  2007-09       Impact factor: 44.182

Review 7.  Conventional and advanced imaging in neuromyelitis optica.

Authors:  Y Barnett; I J Sutton; M Ghadiri; L Masters; R Zivadinov; M H Barnett
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-13       Impact factor: 3.825

8.  Structural brain abnormalities are related to retinal nerve fiber layer thinning and disease duration in neuromyelitis optica spectrum disorders.

Authors:  Felipe von Glehn; Sven Jarius; Rodrigo Pessoa Cavalcanti Lira; Maria Carolina Alves Ferreira; Fadua H Ribeiro von Glehn; Stella Maris Costa E Castro; Guilherme Coco Beltramini; Felipe Pg Bergo; Alessandro S Farias; Carlos Otávio Brandão; Brigitte Wildemann; Benito P Damasceno; Fernando Cendes; Leonilda M B Santos; Clarissa Lin Yasuda
Journal:  Mult Scler       Date:  2014-01-29       Impact factor: 6.312

9.  Evidence of early cortical atrophy in MS: relevance to white matter changes and disability.

Authors:  N De Stefano; P M Matthews; M Filippi; F Agosta; M De Luca; M L Bartolozzi; L Guidi; A Ghezzi; E Montanari; A Cifelli; A Federico; S M Smith
Journal:  Neurology       Date:  2003-04-08       Impact factor: 9.910

10.  White matter atrophy and cognitive dysfunctions in neuromyelitis optica.

Authors:  Frederic Blanc; Vincent Noblet; Barbara Jung; François Rousseau; Felix Renard; Bertrand Bourre; Nadine Longato; Nadjette Cremel; Laure Di Bitonto; Catherine Kleitz; Nicolas Collongues; Jack Foucher; Stephane Kremer; Jean-Paul Armspach; Jerome de Seze
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

View more
  10 in total

1.  Altered neurovascular coupling in neuromyelitis optica.

Authors:  Xi Guo; Jiajia Zhu; Ningnannan Zhang; Linjie Zhang; Yuan Qi; Huanhuan Cai; Xue Zhang; Jie Sun; Qiuhui Wang; Li Yang; Fu-Dong Shi; Chunshui Yu
Journal:  Hum Brain Mapp       Date:  2018-10-13       Impact factor: 5.038

2.  Chronic Cognitive Impairment in AQP4+ NMOSD With Improvement in Cognition on Eculizumab: A Report of Two Cases.

Authors:  Georges Saab; David G Munoz; Dalia L Rotstein
Journal:  Front Neurol       Date:  2022-05-13       Impact factor: 4.086

3.  Subregional structural and connectivity damage in the visual cortex in neuromyelitis optica.

Authors:  Huanhuan Cai; Jiajia Zhu; Ningnannan Zhang; Qiuhui Wang; Chao Zhang; Chunsheng Yang; Jie Sun; Xianting Sun; Li Yang; Chunshui Yu
Journal:  Sci Rep       Date:  2017-02-03       Impact factor: 4.379

4.  Multimodal magnetic resonance imaging in relation to cognitive impairment in neuromyelitis optica spectrum disorder.

Authors:  Su-Hyun Kim; Eun Young Park; Boram Park; Jae-Won Hyun; Na Young Park; AeRan Joung; Sang Hyun Lee; Ho Jin Kim
Journal:  Sci Rep       Date:  2017-08-23       Impact factor: 4.379

5.  Comparison of spontaneous brain activity revealed by regional homogeneity in AQP4-IgG neuromyelitis optica-optic neuritis versus MOG-IgG optic neuritis patients: a resting-state functional MRI study.

Authors:  Junqing Wang; Yuan Tian; Yi Shao; Hui Feng; Limin Qin; Weiwei Xu; Hongjuan Liu; Quangang Xu; Shihui Wei; Lin Ma
Journal:  Neuropsychiatr Dis Treat       Date:  2017-10-24       Impact factor: 2.570

6.  Deep Gray Matter Iron Content in Neuromyelitis Optica and Multiple Sclerosis.

Authors:  Adam Pudlac; Andrea Burgetova; Petr Dusek; Petra Nytrova; Manuela Vaneckova; Dana Horakova; Jan Krasensky; Lukas Lambert
Journal:  Biomed Res Int       Date:  2020-05-19       Impact factor: 3.411

7.  Transdiagnostic hippocampal damage patterns in neuroimmunological disorders.

Authors:  Josephine Heine; Harald Prüß; Michael Scheel; Alexander U Brandt; Stefan M Gold; Thorsten Bartsch; Friedemann Paul; Carsten Finke
Journal:  Neuroimage Clin       Date:  2020-11-27       Impact factor: 4.881

8.  Altered Microstructure of Cerebral Gray Matter in Neuromyelitis Optica Spectrum Disorder-Optic Neuritis: A DKI Study.

Authors:  Hanjuan Zhang; Qing Li; Lei Liu; Xiaoxia Qu; Qian Wang; Bingbing Yang; Junfang Xian
Journal:  Front Neurosci       Date:  2021-12-20       Impact factor: 4.677

9.  Association of subcortical structural shapes with fatigue in neuromyelitis optica spectrum disorder.

Authors:  Jin Myoung Seok; Wanzee Cho; Doo-Hwan Son; Jong Hwa Shin; Eun Bin Cho; Sung Tae Kim; Byoung Joon Kim; Joon-Kyung Seong; Ju-Hong Min
Journal:  Sci Rep       Date:  2022-01-28       Impact factor: 4.379

Review 10.  Cognitive impairment in NMOSD-More questions than answers.

Authors:  Dominika Czarnecka; Magdalena Oset; Iwona Karlińska; Mariusz Stasiołek
Journal:  Brain Behav       Date:  2020-10-06       Impact factor: 2.708

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.